Sort
39,280 grants matching “leukemia”
The Cebpa Enhancer in Normal Hematopoiesis and Progression to AML
$405,000Alan D Friedman · Johns Hopkins University · R01 · FY2016 · HL
The Roles and Regulation of BRCA1 in Hematopoiesis
$405,000Theodora S Ross · Ut Southwestern Medical Center · R01 · FY2019 · HL
The Cebpa Enhancer in Normal Hematopoiesis and Progression to AML
$405,000Alan D Friedman · Johns Hopkins University · R01 · FY2017 · HL
Effector T-cell trafficking in graft-versus-host disease
$405,000Ran Reshef · Columbia University Health Sciences · R01 · FY2023 · HL
Effector T-cell trafficking in graft-versus-host disease
$405,000Ran Reshef · Columbia University Health Sciences · R01 · FY2021 · HL
Development of a Novel Immunotherapeutic for Acute Myeloid Leukemia
$404,995Gary G. Altman · Cambium Oncology Llc · R44 · FY2024 · CA
Control of Retrovirus CNS Disease by redox modulation
$404,989Paul K Wong · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · NS
Characterizing the MSI2 network in leukemia
$404,981Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Characterizing the MSI2 network in leukemia
$404,981Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Genomic instability causes imatinib resistance in CML
$404,972Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2009 · CA
BRD4 Contributes to the Regulation of Alternative Splicing
$404,964Dinah S. Singer · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Redox Regulation of SERCA by Nitric Oxide
$404,951Richard A Cohen · Boston University Medical Campus · R01 · FY2012 · HL
ANALYSIS OF MULTIPLE CHIMERIC TRANSCRIPTS IN THE T(3;21)
$404,933University Of Illinois At Chicago · R01 · FY2003 · CA
Mapping for Specialized Domains for FCeRI Signaling & Internalization
$404,915Bridget S Wilson · University Of New Mexico Health Scis Ctr · R01 · FY2009 · AI
Molecular Analysis of Del(9q) Acute Myeloid Leukemia
$404,909David A Sweetser · Massachusetts General Hospital · R01 · FY2007 · CA
Project 1: Mitotic Gene Bookmarking as an Epigenetic Mechanism to Maintain the Mammary Epithelial Phenotype
$404,901Gary S. Stein · University Of Vermont & St Agric College · P01 · FY2023 · CA
APOBEC proteins as drivers of chromosomal translocations in solid cancers
$404,888Roberto Chiarle · Boston Children'S Hospital · R01 · FY2018 · CA
Defining the impact of mutant oncogene zygosity
$404,888Sarat Chandarlapaty · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Defining the impact of mutant oncogene zygosity
$404,888Sarat Chandarlapaty · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
APOBEC proteins as drivers of chromosomal translocations in solid cancers
$404,888Roberto Chiarle · Boston Children'S Hospital · R01 · FY2021 · CA
APOBEC proteins as drivers of chromosomal translocations in solid cancers
$404,888Roberto Chiarle · Boston Children'S Hospital · R01 · FY2020 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP CLINICAL TRIALS
$404,885Northwestern University · U10 · FY2000 · CA
Hepatitis B virus integrations in KMT2B drive hepatocellular carcinoma
$404,870Jian Cao · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA
Cognitive Impairment, Multimorbidity, and end-of-life care in older cancer patients
$404,835Stanton L Gerson · Case Western Reserve University · P30 · FY2020 · CA
Dissecting and Targeting RB1-Mutant Osteosarcoma
$404,808Dung-Fang Lee · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · CA